Home › DEEPA › Filing
🔔 Get instant alerts when DEEPA files quarterly results on BSE Start free trial →

General Updates

Filed: 30 Sep 2026, 00:05 IST Exchange: NSE Category: Financial Results — Investor Presentation
AI summary - Q1 FY27 revenue grew 39% YoY to INR 4,311 Mn; EBITDA margin 8.98%, down 34 bps YoY - PAT grew 27% YoY to INR 268 Mn; PAT margin contracted 58 bps YoY - EBITDA margin decline due to higher employee costs for new manufacturing facility - Finance costs increased due to working capital for new sales office and manufacturing facility - Growth strategy includes in-house manufacturing in Hyderabad and expansion in Southern India - Product portfolio diversification with increased design team and new categories - Strong customer base with 373 customers across 13 states and 1 UT - Operational revenue mix: 99% processing & manufacturing, 0.89% job work - Job work volume and revenue increased YoY, supporting asset-light model
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 DEEPA — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
⚡
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add DEEPA to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Deepa Jewellers Limited

Important. The summary above is generated automatically from Deepa Jewellers Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.